(Q30863574)

27 June 2017

title

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities (English)

1 reference

27 June 2017

C Robinson

1

1 reference

27 June 2017

M Callow

2

1 reference

27 June 2017

S Stevenson

3

1 reference

27 June 2017

B Scott

4

1 reference

27 June 2017

B W Robinson

5

1 reference

27 June 2017

R A Lake

6

1 reference

27 June 2017

publication date

1 May 2000

1 reference

American Journal of Respiratory Cell and Molecular Biology

27 June 2017

published in

1 reference

27 June 2017

volume

22

1 reference

27 June 2017

issue

5

1 reference

27 June 2017

page(s)

550-556

1 reference

Establishment of a murine model of malignant mesothelioma

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Generation of an antitumour immune response to a murine mesothelioma cell line by the transfection of allogeneic MHC genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Sera from patients with malignant mesothelioma can contain autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Serological analysis of human tumor antigens: molecular definition and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

A mouse mutant p53 product recognized by CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Cloning and domain structure of the mammalian splicing factor U2AF

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Eukaryotic DNA topoisomerase II beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Cloning of mammalian Ire1 reveals diversity in the ER stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

21 January 2018

A new look for the 1990s

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.22.5.3930

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.22.5.3930

1 reference

27 June 2017

1 reference